S. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA 1989, 86, 5810814. Hussain, M.M.; Maxfield, F.R.; Mas-Oliva, J.; Tabas, I.; Ji, Z.S.; Innerarity, T.L.; Mahley, R.W. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 1991, 266, 139363940. Beisiegel, U.; Weber, W.; Bengtsson-Olivecrona, G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA 1991, 88, 8342346. Goldstein, J.L.; Brown, M.S. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 43138. Lambert, G.; Sjouke, B.; Choque, B.; Kastelein, J.J.; Hovingh, G.K. The PCSK9 decade: Thematic Review Series: New Lipid and Lipoprotein Targets for the Therapy of Cardiometabolic Ailments. J. Lipid Res. 2012, 53, 2515524. Raal, F.; Scott, R.; Somaratne, R.; Bridges, I.; Li, G.; Wasserman, S.M.; Stein, E.A. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin kind 9 serine protease in individuals with heterozygous familial hypercholesterolemia: The reduction of LDL-C with PCSK9 inhibition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) randomized trial. Circulation 2012, 126, 2408417. Patsch, J.R.; Miesenbock, G.; Hopferwieser, T.; Muhlberger, V.; Knapp, E.; Dunn, J.K.; Gotto, A.M., Jr.; Patsch, W. Relation of triglyceride metabolism and coronary artery illness. Research within the postprandial state. Arterioscler. Thromb. 1992, 12, 1336345. Engelberg, H. Serum lipemia: An overlooked lead to of tissue hypoxia. Cardiology 1983, 70, 27379. Simons, L.A.; Dwyer, T.; Simons, J.; Bernstein, L.; Mock, P.; Poonia, N.S.; Balasubramaniam, S.; Baron, D.; Branson, J.; Morgan, J.; et al. Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study. Atherosclerosis 1987, 65, 18189. Ryu, J.E.; Howard, G.; Craven, T.E.; Bond, M.G.; Hagaman, A.P.; Crouse, J.R., III. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992, 23, 82328. Karpe, F.; Steiner, G.; Uffelman, K.; Olivecrona, T.; Hamsten, A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994, 106, 837. Meyer, E.; Westerveld, H.T.; de Ruyter-Meijstek, F.C.; van Greevenbroek, M.M.; Rienks, R.; van Rijn, H.J.; Erkelens, D.W.; de Bruin, T.W. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic girls with greater than 70 stenotic coronary artery illness: A case-control study. Atherosclerosis 1996, 124, 22135. Groot, P.Velagliflozin Inhibitor H.EIPA medchemexpress ; van Stiphout, W.PMID:23773119 A.; Krauss, X.H.; Jansen, H.; van Tol, A.; van Ramshorst, E.; Chin-On, S.; Hofman, A.; Cresswell, S.R.; Havekes, L. Postprandial lipoprotein metabolism in normolipidemic males with and without having coronary artery disease. Arterioscler. Thromb. 1991, 11, 65362.Nutrients 2013, 5 41.42.43. 53.54.Ginsberg, H.N.; Jones, J.; Blaner, W.S.; Thomas, A.; Karmally, W.; Fields, L.; Blood, D.; Begg, M.D. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged guys and women. Arterioscler. Thromb. Vasc. Biol. 1995, 15, 1829838. Sakata, K.; Miho, N.; Shirotani, M.; Yoshida, H.; Takada, Y.; Takada, A. Remnant-like particl.